124 related articles for article (PubMed ID: 15314976)
1. Expression of p53 gene in stage IIIA non-small cell lung cancer in patients after neoadjuvant chemotherapy with Vepesid and Cisplatin.
Mańdziuk S; Dudzisz-Sledź M; Korszeń-Pilecka I; Milanowski J; Wojcierowski J; Korobowicz E
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):154-7. PubMed ID: 15314976
[TBL] [Abstract][Full Text] [Related]
2. Expression of p21 and bcl-2 proteins in paraffin-embedded preparations of non-small cell lung cancer in stage IIIA after Etoposide and Cisplatin induced chemotherapy.
Mańdziuk S; Dudzisz-Sledź M; Korszeń-Pilecka I; Milanowski J; Wojcierowski J; Korobowicz E
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):149-53. PubMed ID: 15314975
[TBL] [Abstract][Full Text] [Related]
3. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ
Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of p53 in non-small cell lung cancer before and after preoperative chemotherapy.
Korobowicz E; Zdunek M
Pol J Pathol; 2000; 51(2):71-6. PubMed ID: 10974929
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy.
Garzetti GG; Ciavattini A; Provinciali M; Di Stefano G; Lucarini G; Goteri G; Biagini G
Anticancer Res; 1996; 16(5B):3229-34. PubMed ID: 8920796
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
[TBL] [Abstract][Full Text] [Related]
7. P53 immunostaining predicts chemosensitivity in non-small cell lung cancer: A preliminary report.
Kawasaki M; Nakanishi Y; Yatsunami J; Takayama K; Ochiai S; Xinhai P; Kuwano K; Hara N
Cancer J Sci Am; 1996; 2(4):217-20. PubMed ID: 9166535
[TBL] [Abstract][Full Text] [Related]
8. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
[TBL] [Abstract][Full Text] [Related]
9. Expression of p21 and bcl-2 proteins and p53 mRNA in surgically resected preparations of non-small cell lung cancer (stage IIIA) after etoposide and cisplatin chemotherapy.
Mańdziuk S; Dudzisz-Sledź M; Rybacka-Chabros B; Zdunek M; Jakubowicz-Klecha A; Korobowicz E; Milanowski J; Wojcierowski J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():175-6. PubMed ID: 11820594
[TBL] [Abstract][Full Text] [Related]
10. Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer.
Kandioler D; Stamatis G; Eberhardt W; Kappel S; Zöchbauer-Müller S; Kührer I; Mittlböck M; Zwrtek R; Aigner C; Bichler C; Tichy V; Hudec M; Bachleitner T; End A; Müller MR; Roth E; Klepetko W
J Thorac Cardiovasc Surg; 2008 May; 135(5):1036-41. PubMed ID: 18455581
[TBL] [Abstract][Full Text] [Related]
11. Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer.
Rusch V; Klimstra D; Venkatraman E; Oliver J; Martini N; Gralla R; Kris M; Dmitrovsky E
Cancer Res; 1995 Nov; 55(21):5038-42. PubMed ID: 7585548
[TBL] [Abstract][Full Text] [Related]
12. Expression of PCNA in non-small cell lung cancer before and after treatment with cisplatin and vepeside.
Zdunek M; Korobowicz E
Pol J Pathol; 2000; 51(2):77-81. PubMed ID: 10974930
[TBL] [Abstract][Full Text] [Related]
13. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line.
Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M
Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533
[TBL] [Abstract][Full Text] [Related]
14. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
[TBL] [Abstract][Full Text] [Related]
15. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer.
Tanaka F; Otake Y; Yanagihara K; Yamada T; Miyahara R; Kawano Y; Li M; Inui K; Wada H
Br J Cancer; 2001 Jan; 84(2):263-9. PubMed ID: 11161386
[TBL] [Abstract][Full Text] [Related]
17. Therapy increases poly-ADP-ribose and p53-Ser392-P levels in recurrent squamous cell lung cancer.
Holownia A; Mroz RM; Kozlowski M; Chyczewska E; Laudanski J; Chyczewski L; Braszko JJ
Neoplasma; 2003; 50(4):266-71. PubMed ID: 12937839
[TBL] [Abstract][Full Text] [Related]
18. [The evaluation of prognostic value of cyclin B1 expression in patients with resected non-small-cell lung cancer stage I-IIIA--preliminary report].
Kosacka M; Korzeniewska A; Jankowska R
Pol Merkur Lekarski; 2010 Feb; 28(164):117-21. PubMed ID: 20369739
[TBL] [Abstract][Full Text] [Related]
19. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients.
Boulay JL; Perruchoud AP; Reuter J; Bolliger C; Herrmann R; Rochlitz C
Cancer Gene Ther; 2000 Sep; 7(9):1215-9. PubMed ID: 11023193
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
